ADVERTISEMENT

Custom Search
ADVERTISEMENT
Helpdesk Support
Today's Health Headlines
(Reuters) - Kansas Governor Sam Brownback on Thursday vetoed a bill expanding eligibility for Medicaid under the federal Affordable Care Act (ACA), saying he could not support legislation that provided tax dollars to Planned Parenthood.

LONDON (Reuters) - Eleven biotech companies and research teams in Britain and the United States were awarded up to $48 million in funding on Thursday to speed development of new antibiotics powerful enough to take on the world's deadliest superbugs.

LONDON (Reuters) - Depression is now the leading cause of ill health and disability worldwide, the World Health Organization (WHO) said on Thursday, with more than 300 million people suffering.

JAKARTA (Reuters) - Indonesia's government has proposed issuing a decree to govern the domestic tobacco industry, a move that could sharply raise cigarette output in the world's fourth-most populous nation, after a bill outlining the changes was opposed by the health ministry and anti-smoking groups.

(Reuters) - An anti-inflammatory drug being developed by Corbus Pharmaceuticals Holdings as an add-on treatment for cystic fibrosis demonstrated promising safety and was well tolerated in a small midstage study, according to data released by the company on Thursday.

(Reuters Health) - Just the initial hospitalizations for firearm-related injuries in the United States cost an average $735 million per year, with the government picking up a large portion of the tab, researchers say.

ZURICH (Reuters) - A new leukemia treatment from Novartis for children and young adults will get priority review from the U.S. Food and Drug Administration (FDA), putting the Swiss drugmaker ahead of rivals working on similar cancer therapies.

BEIJING (Reuters) - China's Ministry of Agriculture reported on Thursday 37 pigs on a farm in the southern Guangdong province had been killed after contracting the O-type strain of foot-and-mouth disease.

LONDON (Reuters) - GlaxoSmithKline's new CEO Emma Walmsley, who takes over on April 1, has won a short-term reprieve from the threat of generic Advair with a delay in U.S. approval for Mylan's copy of the blockbuster lung inhaler.

LONDON (Reuters) - Iranian sovereign fund IFIC is targeting investments in the healthcare and high-tech sectors in the hope of improving the lives of Iranians, Vahid Sharif, an investment manager at the fund, said on Thursday.

ADVERTISEMENT
Welcome Guest
Username: 
Password:
Not a member? Sign Up!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
ADVERTISEMENT
loading